Emergent BioSolutions Inc. (EBS) Insider Trading Activity

NYSE$5.84-0.41 (-6.56%)
Market Cap
$320.46M
Sector
Healthcare
Industry
Drug Manufacturers—Specialty & Generic
Rank in Sector
523 of 849
Rank in Industry
27 of 48

EBS Insider Trading Activity

EBS Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$0
0
0
Sells
$1,259,212
11
100

Related Transactions

Williams Paul AnthonySVP, Products Business
0
$0
3
$78,550
$-78,550
Katkin Keithdirector
0
$0
1
$128,183
$-128,183
Zoon Kathryn Cdirector
0
$0
1
$144,453
$-144,453
Dayal Sujata Tyagidirector
0
$0
2
$201,130
$-201,130
Richard Ronalddirector
0
$0
1
$263,077
$-263,077
DeGolyer Donald Wdirector
0
$0
3
$443,818
$-443,818

About Emergent BioSolutions Inc.

Emergent BioSolutions Inc. is a life sciences company dedicated to providing vital preparedness and response solutions for a wide range of public health threats (PHTs) across the United States. These threats encompass accidental, deliberate, and naturally occurring events, including chemical, biological, radiological, nuclear, and explosives (CBRNE) incidents, emerging infectious diseases, travel-related health risks, and acute emergency care situations. The company's current product portfolio features essential vaccines and treatments such as …

Insider Activity of Emergent BioSolutions Inc.

Over the last 12 months, insiders at Emergent BioSolutions Inc. have bought $0 and sold $1.26M worth of Emergent BioSolutions Inc. stock.

On average, over the past 5 years, insiders at Emergent BioSolutions Inc. have bought $231,090 and sold $537,317 worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 60,000 shares for transaction amount of $349,800 was made by PAPA JOSEPH C (President and CEO) on 2025‑05‑13.

List of Insider Buy and Sell Transactions, Emergent BioSolutions Inc.

2026-10-07SaleDeGolyer Donald Wdirector
17,800
0.0346%
$7.09
$126,202
-5.66%
2026-10-01SaleWilliams Paul AnthonySVP, Products Business
3,000
0.006%
$6.53
$19,590
+6.91%
2026-07-01SaleWilliams Paul AnthonySVP, Products Business
3,000
0.0059%
$8.40
$25,200
-18.48%
2026-05-01SaleDeGolyer Donald Wdirector
15,481
0.0297%
$8.40
$129,994
-14.40%
2026-05-01SaleDayal Sujata Tyagidirector
13,761
0.0264%
$8.40
$115,610
-14.40%
2026-05-01SaleZoon Kathryn Cdirector
17,202
0.033%
$8.40
$144,453
-14.40%
2026-04-30SaleKatkin Keithdirector
15,481
0.0311%
$8.28
$128,183
-11.79%
2026-04-01SaleWilliams Paul AnthonySVP, Products Business
4,000
0.0078%
$8.44
$33,760
-9.55%
2025-12-05SaleRichard Ronalddirector
21,984
0.041%
$11.97
$263,077
-31.55%
2025-11-10SaleDeGolyer Donald Wdirector
17,801
0.0342%
$10.54
$187,623
-25.20%
2025-11-07SaleDayal Sujata Tyagidirector
8,552
0.0127%
$10.00
$85,520
-19.00%
2025-10-07SaleGlessner ColeenEVP, Quality & Ethics, and CPL
30,608
0.0578%
$10.00
$306,080
-15.42%
2025-08-15SaleZoon Kathryn Cdirector
7,086
0.0133%
$8.87
$62,853
-1.30%
2025-08-12SaleDeGolyer Donald Wdirector
7,844
0.0156%
$8.65
$67,831
-1.35%
2025-05-23SaleKatkin Keithdirector
7,844
0.0142%
$6.30
$49,417
+36.33%
2025-05-13PurchasePAPA JOSEPH CPresident and CEO
60,000
0.1096%
$5.83
$349,800
+48.13%
2025-03-12SaleFowler Neal Franklindirector
35,000
0.0611%
$5.83
$204,050
+35.77%
2025-03-12SaleZoon Kathryn Cdirector
10,000
0.0171%
$5.73
$57,300
+35.77%
2024-11-12SaleDeGolyer Donald Wdirector
25,000
0.0461%
$10.91
$272,750
-26.81%
2024-11-11SaleWhite Marvin Ldirector
14,287
0.0264%
$11.97
$171,015
-33.42%
Total: 495
*Gray background shows transactions not older than one year

Insider Historical Profitability

7.33%
PAPA JOSEPH CPresident and CEO
342500
0.668%
$2.14M10
+48.13%
Abdun-Nabi DanielCEO
142617
0.2782%
$891,356.25248
+25.65%
LINDAHL RICHARD SEVP, Chief Financial Officer
39919
0.0779%
$249,493.7510
<0.0001%
Havey AdamEVP, Business Operations
38190
0.0745%
$238,687.50124
+10.39%
Elsey R DonChief Financial Officer
22199
0.0433%
$138,743.7519
<0.0001%
Zink ThomasSVP & CMO
990
0.0019%
$6,187.5020
<0.0001%
*Gray background shows insiders who have made transactions during last year

Historical Insider Profitability vs. Competitors

$2,101,005
2135
-11.51%
$64.58M
$131,310,609
62
26.99%
$107.44M
$33,884,330
45
12.56%
$223.45M
$98,035,963
43
-10.97%
$486.79M
$11,542,910
40
56.19%
$1.07B

EBS Institutional Investors: Active Positions

Increased Positions103+54.21%5M+12.93%
Decreased Positions80-42.11%4M-8.54%
New Positions42New2MNew
Sold Out Positions28Sold Out1MSold Out
Total Postitions213+12.11%43M+4.39%

EBS Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Blackrock, Inc.$53,332.008.04%4.26M-97,752-2.24%2025-09-30
Oak Hill Advisors Lp$45,203.006.82%3.61M00%2025-09-30
Vanguard Group Inc$44,294.006.68%3.54M-43,543-1.22%2025-09-30
State Street Corp$30,596.004.62%2.45M+705,004+40.5%2025-09-30
American Century Companies Inc$29,804.004.5%2.38M+90,216+3.94%2025-09-30
Dimensional Fund Advisors Lp$26,776.004.04%2.14M+291,308+15.76%2025-09-30
Palisade Capital Management, Lp$17,839.002.69%1.43M+326,260+29.67%2025-09-30
Charles Schwab Investment Management Inc$17,286.002.61%1.38M+276,566+25.02%2025-09-30
Geode Capital Management, Llc$15,996.002.41%1.28M-305-0.02%2025-09-30
Acadian Asset Management Llc$14,733.002.22%1.18M+203,071+20.84%2025-09-30

Financial Ratios

Summary
Comparison with Competitors

Price to Earnings

Price/Earnings to Growth

Price to Sales

Price to Book

Price/Free Cash Flow

Analyst Recommendations

Analyst Price Targets

Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.